Endocrinologist Dr Philip Kelly of LondonSwissMedical discusses therapy for lipid disorders including new treatments to keep the risk of car

Differentiating the causes of thirst and polyuria is critical as the treatment is completely different dependent on the cause. Diabetes mell

Dr Philip Kelly discusses the options for patients with heavy periods, including simple non-hormonal options, hormonal treatment, interventi

Canagliflozin reduces major adverse cardiovascular events (MACE) in patients with T2DM. Big paper in the NEJM, (the trials sponsored by...

Teprotumumab is a new monoclonal antibody against the IGF-I receptor that has shown promise at reducing proptosis in moderate to sever Grave

Dr Philip Kelly, consultant endocrinologist at King's College Hospital discusses Graves' thyrotoxicosis, what is it, how does it pre

Excess sweating is common - it is important to distinguish primary from secondary hyperhidrosis. This often requires assessment by an experi

PE, who gets it and what can we do about it? What to do if chronic breathlessness develops and chronic pulmonary thromboembolic hypertension

How does having breast cancer affect the ovaries and how might ovarian function and oestrogen affect treatment options - particularly the u

Do not use laboratory tests routinely to diagnose menopause or perimenopause in healthy women over 45 years of age. In younger women the FSH